Torbjørn Furuseth

Torbjørn Furuseth has a diverse work experience spanning multiple industries. Torbjørn is currently the CEO and Co-founder of DoMore Diagnostics, a position they have held since October 2021. Prior to this, they worked as an Advisor at Antler starting from September 2018. From September 2018 to October 2021, they served as the CFO of Targovax ASA. Before that, they were the CFO of Lytix Biopharma from February 2017 to September 2018. Torbjørn also held various roles at Aker BioMarine AS, including Executive Vice President of Innovation from June 2015 to March 2017 and SVP, Head of Pharma and Innovation from November 2014 to June 2015. Torbjørn was the VP of Commercial Development at Trygg Pharma from October 2013 to January 2017. Torbjørn's earlier experience includes working as an Engagement Manager at McKinsey & Company from January 2008 to October 2013. Torbjørn worked as a Resident at a hospital in Molde from August 2006 to January 2008. Additionally, they also served as a Team Physician for Molde Football Club in 2006, and as a Medical Advisor in the Norwegian Army from January 2003 to 2007.

Torbjørn Furuseth's education history includes the following:

- In 1994-1997, they attended Molde VGS, where they pursued unspecified studies.

- From 1998 to 2004, they enrolled in the Norwegian School of Science and Technology (NTNU) and received a Doctor of Medicine (M.D.) degree with a focus on Medicine.

- Concurrently, from 1998 to 2004, Furuseth also studied Patenting and Commercialisation in Biotech and Medtech at the Norwegian University of Science and Technology (NTNU).

- In 2001, they briefly attended the Norwegian School of Entrepreneurship, focusing on Entrepreneurship.

- In 2008, Furuseth completed the McKinsey Mini-MBA program, acquiring additional knowledge without a specific degree or field of study.